Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
Am J Cardiovasc Drugs
; 13(2): 79-85, 2013 Apr.
Article
em En
| MEDLINE
| ID: mdl-23539170
ABSTRACT
In the coming years, genomics will impact clinical practice in multiple ways. However, one of the most important applications will be in the determination of the best treatments in personalized medicine. This is, in fact, one of the fields in which genetic variants have already been most successful and useful to clinicians. Here, we briefly review the current state of the art on pharmacogenomics and its applications to modern cardiovascular medicine.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacogenética
/
Varfarina
/
Inibidores da Agregação Plaquetária
/
Doenças Cardiovasculares
/
Inibidores de Hidroximetilglutaril-CoA Redutases
/
Medicina de Precisão
Limite:
Humans
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article